United Capital Financial Advisors LLC Makes New Investment in Healthpeak Properties, Inc. $DOC

United Capital Financial Advisors LLC purchased a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 56,309 shares of the real estate investment trust’s stock, valued at approximately $1,205,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. New York Life Investment Management LLC boosted its stake in Healthpeak Properties by 65.8% in the 4th quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust’s stock worth $2,510,000 after purchasing an additional 61,952 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al raised its stake in shares of Healthpeak Properties by 176.0% in the 4th quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 320,040 shares of the real estate investment trust’s stock valued at $5,146,000 after purchasing an additional 204,100 shares during the period. Swedbank AB boosted its position in shares of Healthpeak Properties by 433.4% during the fourth quarter. Swedbank AB now owns 849,215 shares of the real estate investment trust’s stock worth $13,655,000 after buying an additional 690,000 shares during the period. Nan Fung Trinity HK Ltd. acquired a new position in shares of Healthpeak Properties during the fourth quarter worth about $2,654,000. Finally, JPMorgan Chase & Co. grew its holdings in shares of Healthpeak Properties by 8.6% during the fourth quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock worth $493,251,000 after buying an additional 2,438,278 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Down 1.2%

NYSE:DOC opened at $20.96 on Friday. Healthpeak Properties, Inc. has a twelve month low of $15.70 and a twelve month high of $22.95. The firm has a market capitalization of $14.45 billion, a price-to-earnings ratio of 59.89, a price-to-earnings-growth ratio of 2.29 and a beta of 1.01. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. The stock’s 50 day moving average price is $21.54 and its two-hundred day moving average price is $19.18.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business had revenue of $771.58 million during the quarter, compared to analysts’ expectations of $725.64 million. During the same period last year, the business earned $0.46 earnings per share. The firm’s revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Equities research analysts expect that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be paid a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 5.8%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 348.57%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the company. UBS Group lifted their target price on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. JPMorgan Chase & Co. upped their price target on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Royal Bank Of Canada raised their price target on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Citigroup boosted their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 11th. Finally, Barclays began coverage on shares of Healthpeak Properties in a report on Tuesday, July 7th. They set an “equal weight” rating and a $23.00 target price for the company. Four analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $21.66.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.